Literature DB >> 1848739

Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST.

R Galard1, J M Gallart, R Catalan, S Schwartz, J M Arguello, J M Castellanos.   

Abstract

OBJECTIVE: The aim of this work was to study the clinical utility of salivary cortisol concentrations in a group of depressed patients undergoing the dexamethasone suppression test (DST) and the correlation of these concentrations with plasma ACTH levels.
METHOD: Twenty outpatients from the psychiatric department of a Barcelona hospital who were diagnosed as having nonendogenous (N = 9) or endogenous (N = 11) depression according to DSM-III criteria and the Newcastle scale participated in the study. The comparison group consisted of 12 healthy volunteers. Blood and saliva samples were taken before and after administration of 1 mg of dexamethasone Salivary cortisol and plasma ACTH concentrations were determined by direct iodine-125 radioimmunoassay with commercial kit reagents.
RESULTS: Predexamethasone salivary cortisol concentrations were significantly higher in the group with endogenous depression than in the comparison group. A significant correlation was obtained between plasma ACTH and predexamethasone salivary cortisol levels in the group with nonendogenous depression and in the comparison subjects.
CONCLUSIONS: These preliminary findings indicate that salivary cortisol could substitute for plasma cortisol in clinical studies in which the DST and hypercortisolemia are evaluated. The lack of correlation between ACTH and cortisol levels in saliva in the group of endogenously depressed patients could indicate a disturbance in the regulation of cortisol secretion in major depression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848739     DOI: 10.1176/ajp.148.4.505

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women.

Authors:  Helen C Fox; Rajita Sinha
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

2.  The impact of a new emotional self-management program on stress, emotions, heart rate variability, DHEA and cortisol.

Authors:  R McCraty; B Barrios-Choplin; D Rozman; M Atkinson; A D Watkins
Journal:  Integr Physiol Behav Sci       Date:  1998 Apr-Jun

3.  Acth and the dexamethasone suppression test in depression.

Authors:  A K Jainer; M Sharma; J K Trivedt; C G Agarwal; S C Tiwari
Journal:  Indian J Psychiatry       Date:  1992-01       Impact factor: 1.759

4.  5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.

Authors:  George I Papakostas; Sarah E Chuzi; Jessica L Sousa; Maurizio Fava
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-30       Impact factor: 5.270

5.  Yukmijihwang-tang for the treatment of xerostomia in the elderly: study protocol for a randomized, double-blind, placebo-controlled, two-center trial.

Authors:  Gajin Han; Jae-Woo Park; Seok-Jae Ko; Jihee Son; Jongki Seon; Juyeon Kim; Seulki Kim; Inkwon Yeo; Bongha Ryu; Jinsung Kim
Journal:  Trials       Date:  2013-09-03       Impact factor: 2.279

Review 6.  Saliva between normal and pathological. Important factors in determining systemic and oral health.

Authors:  Gabriela Iorgulescu
Journal:  J Med Life       Date:  2009 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.